Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions
A Look at What Drug Manufacturers are Likely Using to Make CAR-T Products
Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
For full access to this article login to GEN Select now.
Flow Cytometry Applications Proliferate
As Use Increases There Is Need to Transform General Expectations into Practical Reality
- Until “BioPharmaceutical Flow Cytometry 2008”, there had been little opportunity for users of flow cytometry in drug discovery/development to get together, share experiences, and discuss pitfalls and future requirements. Over 100 delegates from around the world attended the recent one-day meeting hosted by AstraZeneca. Attendees included small- to mid-sized ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.